GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) » Definitions » Revenue

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) Revenue : TND Mil (TTM As of . 20)


View and export this data going back to 2001. Start your Free Trial

What is Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Revenue?

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's revenue for the six months ended in . 20 was TND0.00 Mil. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T does not have enough years/quarters to calculate its revenue for the trailing twelve months (TTM) ended in . 20. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Revenue per Share for the six months ended in . 20 was TND0.00. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Revenue Historical Data

The historical data trend for Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Revenue Chart

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Annual Data
Trend
Revenue

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Semi-Annual Data
Revenue

Competitive Comparison of Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Revenue distribution charts can be found below:

* The bar in red indicates where Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Revenue falls into.



Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T  (XTUN:SIPHA) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Revenue Related Terms

Thank you for viewing the detailed overview of Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) Business Description

Traded in Other Exchanges
N/A
Address
Fondouk Choucha, Ben Arous, TUN, 2013
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T is a Tunisia-based company mainly engaged in manufacturing and distributing medicines and drugs. The company also has its own research and development process to develop generic drugs. It offers pharmaceutical, dietary, hygiene, and cosmetic products in dry, liquid and pasty forms.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) Headlines

No Headlines